Latest Headlines

Latest Headlines

Synthes cautious despite encouraging results

Swiss devicemaker Synthes is eyeing 2011 sales growth in the mid-to-high single digit percentage range after posting a 10.2 percent rise in full-year net earnings, Reuters is reporting today.

Synthes to divest Norian as part of settlement with gov't.

The American unit of multinational devicemaker Synthes has agreed to divest its Norian subsidiary as part of a settlement related to the conduct of a clinical trial for a bone cement product. The

Medtronic scores win in SSI case

The U.S. Court of Appeals for the Federal Circuit has reversed parts of a lower court ruling that doubled $5.7 million in damages against Medtronic in a case involving intervertebral implants. Spine